JP2002503639A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002503639A5 JP2002503639A5 JP2000520153A JP2000520153A JP2002503639A5 JP 2002503639 A5 JP2002503639 A5 JP 2002503639A5 JP 2000520153 A JP2000520153 A JP 2000520153A JP 2000520153 A JP2000520153 A JP 2000520153A JP 2002503639 A5 JP2002503639 A5 JP 2002503639A5
- Authority
- JP
- Japan
- Prior art keywords
- interleukin
- specific
- antigen
- molecule
- growth factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6515597P | 1997-11-10 | 1997-11-10 | |
| US60/065,155 | 1997-11-10 | ||
| US7581198P | 1998-02-24 | 1998-02-24 | |
| US60/075,811 | 1998-02-24 | ||
| US10745598P | 1998-11-06 | 1998-11-06 | |
| US60/107455 | 1998-11-06 | ||
| PCT/US1998/023957 WO1999024066A2 (en) | 1997-11-10 | 1998-11-10 | Methods and compositions for enhancing immune response and for the production of in vitro mabs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009144707A Division JP2009292818A (ja) | 1997-11-10 | 2009-06-17 | 免疫応答を増強するため、およびインビトロでのモノクローナル抗体の産生のための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002503639A JP2002503639A (ja) | 2002-02-05 |
| JP2002503639A5 true JP2002503639A5 (enExample) | 2006-01-05 |
| JP4588210B2 JP4588210B2 (ja) | 2010-11-24 |
Family
ID=27370737
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000520153A Expired - Fee Related JP4588210B2 (ja) | 1997-11-10 | 1998-11-10 | 免疫応答を増強するため、およびインビトロでのモノクローナル抗体の産生のための方法および組成物 |
| JP2009144707A Pending JP2009292818A (ja) | 1997-11-10 | 2009-06-17 | 免疫応答を増強するため、およびインビトロでのモノクローナル抗体の産生のための方法および組成物 |
| JP2012214639A Pending JP2013014616A (ja) | 1997-11-10 | 2012-09-27 | 免疫応答を増強するため、およびインビトロでのモノクローナル抗体の産生のための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009144707A Pending JP2009292818A (ja) | 1997-11-10 | 2009-06-17 | 免疫応答を増強するため、およびインビトロでのモノクローナル抗体の産生のための方法および組成物 |
| JP2012214639A Pending JP2013014616A (ja) | 1997-11-10 | 2012-09-27 | 免疫応答を増強するため、およびインビトロでのモノクローナル抗体の産生のための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1039933B8 (enExample) |
| JP (3) | JP4588210B2 (enExample) |
| AT (1) | ATE317269T1 (enExample) |
| AU (3) | AU757357B2 (enExample) |
| CA (1) | CA2309602C (enExample) |
| DE (1) | DE69833455T2 (enExample) |
| NZ (1) | NZ504292A (enExample) |
| WO (1) | WO1999024066A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010055581A1 (en) | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
| US6407218B1 (en) | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
| US7229841B2 (en) | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
| EP1133994A1 (en) * | 2000-03-11 | 2001-09-19 | Biognostik Gesellschaft für biomolekulare Diagnostik mbH | A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA" |
| CA2448607C (en) * | 2001-04-30 | 2013-01-22 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
| EP1694301A4 (en) * | 2003-12-02 | 2009-11-18 | Cytimmune Sciences Inc | METHOD AND COMPOSITIONS FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES |
| WO2005072893A1 (en) * | 2004-01-28 | 2005-08-11 | Cytimmune Sciences, Inc. | Functionalized colloidal metal compositions and methods |
| KR100836745B1 (ko) * | 2007-01-31 | 2008-06-10 | (주)두비엘 | Ｈｂｖ 백신 및 그의 제조 방법 |
| US8877156B2 (en) | 2007-06-26 | 2014-11-04 | New York University | Contrast agents anchored by thiols on nanoparticles |
| EP2200932A4 (en) * | 2007-09-21 | 2014-09-10 | Cytimmune Sciences Inc | NANOTHERAPEUTIC COLLOIDAL METAL COMPOSITIONS AND METHODS |
| EP2219458B1 (en) | 2007-11-08 | 2015-07-15 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
| JP5364310B2 (ja) * | 2008-07-14 | 2013-12-11 | アルフレッサファーマ株式会社 | 反応性物質が結合した微小粒子の安定化方法および該微小粒子含有試薬 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57502090A (enExample) * | 1980-07-18 | 1982-11-25 | ||
| CA1214123A (en) * | 1983-01-20 | 1986-11-18 | Masashi Matsui | Cell lines for use in the preparation of hybridoma cells |
| JPS61104796A (ja) * | 1984-10-26 | 1986-05-23 | Chemo Sero Therapeut Res Inst | モノクロ−ナル抗体の製造方法 |
| JPS62162963A (ja) * | 1986-01-10 | 1987-07-18 | Sadao Shiosaka | 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法 |
| CA2158475C (en) * | 1993-03-18 | 2009-06-02 | Lawrence Tamarkin | Composition and method for reducing toxicity of biologically-active factors |
| JPH07227299A (ja) * | 1994-02-14 | 1995-08-29 | Kyoto Daiichi Kagaku:Kk | Ｄｎａの特定塩基配列の検出方法及びその装置 |
| US5686578A (en) * | 1994-08-05 | 1997-11-11 | Immunomedics, Inc. | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| JPH09107980A (ja) * | 1995-08-17 | 1997-04-28 | Japan Tobacco Inc | 新規生理活性タンパク |
| AU760035B2 (en) * | 1997-11-10 | 2003-05-08 | Cytimmune Sciences, Inc. | Compositions and methods for targeted delivery of factors |
| US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
-
1998
- 1998-11-10 WO PCT/US1998/023957 patent/WO1999024066A2/en not_active Ceased
- 1998-11-10 EP EP98958518A patent/EP1039933B8/en not_active Expired - Lifetime
- 1998-11-10 CA CA2309602A patent/CA2309602C/en not_active Expired - Fee Related
- 1998-11-10 AU AU14548/99A patent/AU757357B2/en not_active Ceased
- 1998-11-10 NZ NZ504292A patent/NZ504292A/xx not_active IP Right Cessation
- 1998-11-10 AT AT98958518T patent/ATE317269T1/de active
- 1998-11-10 JP JP2000520153A patent/JP4588210B2/ja not_active Expired - Fee Related
- 1998-11-10 DE DE69833455T patent/DE69833455T2/de not_active Expired - Lifetime
-
2003
- 2003-05-23 AU AU2003204353A patent/AU2003204353B2/en not_active Ceased
-
2006
- 2006-11-10 AU AU2006235956A patent/AU2006235956B2/en not_active Ceased
-
2009
- 2009-06-17 JP JP2009144707A patent/JP2009292818A/ja active Pending
-
2012
- 2012-09-27 JP JP2012214639A patent/JP2013014616A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lauw et al. | Proinflammatory effects of IL-10 during human endotoxemia | |
| JP2002503639A5 (enExample) | ||
| JP2007500721A5 (enExample) | ||
| Kiyono et al. | NALT-versus Peyer's-patch-mediated mucosal immunity | |
| US6004763A (en) | Antigen-carrying microparticles and their use in the induction of humoral or cellular responses | |
| Forkel et al. | Dysregulation of group 3 innate lymphoid cells in the pathogenesis of inflammatory bowel disease | |
| US7790167B2 (en) | Methods and compositions for enhancing immune response and for the production of in vitro Mabs | |
| Esser et al. | Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus | |
| US20230265150A1 (en) | A fusion proteon of stromal cell-derived factor-1 (sdf-1) and interleukin-2 (il-2) and applications thereof | |
| CA2309602A1 (en) | Methods and compositions for enhancing immune response and for the production of in vitro mabs | |
| JP2001522818A5 (enExample) | ||
| Takaoka et al. | A critical role for mouse CXC chemokine (s) in pulmonary neutrophilia during Th type 1-dependent airway inflammation | |
| Kamboj et al. | Immunization with Haemophilus influenzae type b-CRM197 conjugate vaccine elicits a mixed Th1 and Th2 CD4+ T cell cytokine response that correlates with the isotype of antipolysaccharide antibody | |
| CA2309604A1 (en) | Compositions and methods for targeted delivery of factors | |
| Sundstedt et al. | Superantigens anergize cytokine production but not cytotoxicity in vivo | |
| Brennan et al. | The importance of T cell interactions with macrophages in rheumatoid cytokine production | |
| Snapper et al. | IFN-γis a potent inducer of Ig secretion by sort-purified murine B cella activated through the mlg, but not the CD40, signaling pathway | |
| SCUDERI et al. | Recombinant interferon-γ stimulates the production of human tumor necrosis factor in vitro | |
| Staren et al. | Overview of biological response modifiers | |
| Taneichi et al. | T cell-independent regulation of IgE antibody production induced by surface-linked liposomal antigen | |
| CN118286410B (zh) | 一种偶联CD8抗体的肿瘤mRNA疫苗的制备方法 | |
| Svenson et al. | Cytokine vaccination: neutralising IL-1α autoantibodies induced by immunisation with homologous IL-1α | |
| Abraham et al. | Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation | |
| Evans et al. | Synergistic interaction of bacterial lipopolysaccharide and the monocyte‐macrophage colony‐stimulating factor: potential quantitative and qualitative changes in macrophage‐produced cytokine bioactivity | |
| US20090081156A1 (en) | Bioactive molecular matrix and methods of use in the treatment of disease |